Spectrum Pharmaceuticals | Utile Per Azione


Fiscal Calendario Efettivo Consenso Precedente Data


Eps Cambiamento Data
AbbVie USD 2.71 0.85 2025-12
Actinium Pharmaceuticals USD -0.51 0.3 2025-03
Agios Pharmaceuticals USD -1.86 0.08 2025-12
Alnylam Pharmaceuticals USD 1.25 1.65 2025-12
Amgen USD 5.29 0.35 2025-12
Arrowhead Research USD 0.22 0.33 2025-12
Astellas Pharma JPY 56.04 11.82 2025-12
AstraZeneca USD 2.12 0.26 2025-12
Bayer EUR 0.57 0.66 2025-09
Biogen USD 1.99 2.82 2025-12
Bristol-Myers Squibb USD 1.26 0.37 2025-12
Coherus Biosciences USD -0.35 0.07 2025-03
Eli Lilly USD 7.54 0.52 2025-12
GlaxoSmithKline GBP 0.26 0.29 2025-12
Incyte USD 1.8 0.46 2025-12
J&J USD 2.46 0.34 2025-12
Karyopharm Therapeutics USD -0.15 0.11 2024-12
Merck USD 2.04 0.54 2025-12
Novartis USD 2.04 0.38 2025-09
Pfizer USD 0.66 0.21 2025-12
Puma Biotechnology USD 0.41 0.5 2024-09
Roche Holding CHF 8.37 2.95 2025-12
Sanofi EUR 1.53 1.38 2025-12
Takeda JPY 65.74 73.57 2025-12
Teva Pharmaceutical Industries USD 2.98 0.43 2025-12
TG Therapeutics USD 0.14 2.29 2025-12


Spectrum Pharmaceuticals Utile Per Azione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2026.